Deliver Your News to the World

CybeRelease: (OTC: VMCS) Segal Cancer Center Selects VisualMED


(CybeRelease, August 9, 2007) Lake Harmony, Pa. - VisualMED Clinical Solutions Corp. (the “Company”) (OTC BB:VMCS) (Frankfurt:VA6.F) announced the acquisition of VisualONCOLOGY, its state-of-the-art interactive, interdisciplinary electronic medical record by the Segal Cancer Center of the Mortimer B. Davis Jewish General Hospital of Montreal. The site, part of the McGill University teaching hospital system, will use VisualONCOLOGY for documentation of patient care, decision support and for the design and execution of protocol chemotherapy. Implementation is starting immediately with an anticipated go-live as early as Q4 of this year. The Cancer Center will take advantage of VisualONCOLOGY’s fully electronic clinical documentation to free additional space for patient care, while VisualONCOLOGY’s cohort-identification and protocol management capabilities will contribute directly to clinical research.

“We look forward to pursuing a real partnership with what we expect to be our flagship oncology center,” said Dr. Alan Brox, Senior Physician at VisualMED, and the company’s Director of Oncology Projects. “The Segal Center’s unique expertise, packaged in our user-friendly application will bring benefits to both of our organizations.”

Dr. Gerald Batist, Director of the Segal Cancer Center and Director of Oncology at McGill University noted that: “Implementing VisualONCOLOGY gives us the opportunity to guide the development of health care information systems as they apply to oncology, as leaders, rather than followers. The promise of electronic health systems has been slow to come to realization, but we are impressed with the possibilities that VisualONCOLOGY has to offer, both in the realm of medication safety and in clinical research support.”

To read the complete release, go to

CybeRelease Gainers are Hoku Scientific, Inc. (Nasdaq: HOKU), Power-One, Inc. (Nasdaq: PWER), SourceForge, Inc. (Nasdaq: LNUX), Harris Stratex Networks, Inc. (Nasdaq: HSTX), Cross Country Healthcare, Inc. (Nasdaq: CCRN), Presstek, Inc. (Nasdaq: PRST) and Liquidity Services, Inc. (Nasdaq: LQDT).

CybeRelease Decliners are Credence Systems Corporation (Nasdaq: CMOS), Methode Electronics, Inc. (Nasdaq: METH), Radio One, Inc. (Nasdaq: ROIAK), CSG Systems International, Inc. (Nasdaq: CSGS), LTX Corporation (Nasdaq: LTXX), SMTC Corporation (Nasdaq: SMTX) and Chordiant Software, Inc. (Nasdaq: CHRD).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation, do no trading of any kind and send No Faxes or Emails.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.